Provided by Tiger Trade Technology Pte. Ltd.

CAR-T Concept

1,871.74
-39.5358-2.07%
Number of Gainers:- -
Number of Losers:2
Number of Flat:- -
PE:- -
High:1,907.06
Open:1,907.06
Low:1,856.82
Close:1,911.59
Volume:3.53M
Turnover:543.46M
Market Cap:482.50B
Float Cap:467.72B

Loading ...

Novartis Ag : Argus Research Raises to Buy From Hold

THOMSON REUTERS
·
2 hours ago

Novartis upgraded to Buy from Hold at Argus

TIPRANKS
·
3 hours ago

Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
18 hours ago

Gilead Sciences Initiated at Buy by Jefferies

Dow Jones
·
Yesterday

Gilead : Jefferies Initiates Coverage With Buy Rating; Price Target $180

THOMSON REUTERS
·
Yesterday

Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Yesterday

Novartis price target raised to CHF 110 from CHF 92 at Berenberg

TIPRANKS
·
Yesterday

Novartis (NVS) Receives a Hold from Berenberg Bank

TIPRANKS
·
Mar 09

These 8 drugs could help fight dementia - and they're already on the market

Dow Jones
·
Mar 07

Funds: What This Top International ETF Is Buying Now -- Barron's

Dow Jones
·
Mar 07

Novartis Shareholders Approve Dividend Raise, Share Capital Reduction

MT Newswires Live
·
Mar 06

Novartis shareholders approve all resolutions proposed by Board of Directors

TIPRANKS
·
Mar 06

Gilead Sciences' HIV Drug Eyed for Local Production by South Africa

MT Newswires Live
·
Mar 06

Berenberg Raises Price Target on Novartis to $141 From $116, Keeps Hold Rating

MT Newswires Live
·
Mar 06

Gilead Sciences Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Mar 06

Gilead Sciences to Buy Arcellx for $115 a Share Plus $5 CVR

Reuters
·
Mar 06

Tango Therapeutics posts FY 2025 collaboration revenue of USD 62.4 million +108.2%

Reuters
·
Mar 05

South Africa seeks local production of Gilead's HIV prevention drug

Reuters
·
Mar 05

What This Top International ETF Is Buying Now -- Barrons.com

Dow Jones
·
Mar 04

Gilead Sciences Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Mar 04